Directors have demonstrated strong support for ASF Group’s recent $10 million rights issue, which will fund investments in its current portfolio and investigate business opportunities. The significant investment by a number of the directors the company’s performance with that of shareholders.
- Forums
- ASX - By Stock
- AFA
- News: ASF Group directors show the way in rights issue
News: ASF Group directors show the way in rights issue
Featured News
Add AFA (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.84M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $7 | 360 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 238888 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1640 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 238888 | 0.003 |
1 | 333666 | 0.002 |
1 | 531061 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1640 | 1 |
0.023 | 24640 | 1 |
0.029 | 43500 | 1 |
0.030 | 100000 | 1 |
0.050 | 6845 | 1 |
Last trade - 15.11pm 13/11/2024 (20 minute delay) ? |
Featured News
AFA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online